Nomura Holdings
RPRX icon

Nomura Holdings’s Royalty Pharma RPRX Stock Holding History

Nomura Holdings’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272K Sell
4,849
-18,116
-79% -$943K ﹤0.01% 1625
2026
Q1 		$1.1M Buy
22,965
+4,694
+26% +$206K ﹤0.01% 1122
2025
Q4 		$706K Buy
+18,271
New +$697K ﹤0.01% 1436
2025
Q2 		– Sell
-17,907
Closed -$557K – 1880
2025
Q1 		$557K Buy
+17,907
New +$568K ﹤0.01% 1454
2023
Q3 		– Sell
-7,250
Closed -$223K – 1606
2023
Q2 		$223K Hold
7,250
– – ﹤0.01% 1162
2023
Q1 		$261K Buy
+7,250
New +$269K ﹤0.01% 1209
2021
Q4 		– Sell
-471,600
Closed -$17.1M – 2436
2021
Q3 		$17.1M Buy
+471,600
New +$18.3M 0.04% 256

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $2.93B AUM 37.21% 1-Year Est. Return

Nomura Holdings's RPRX Position: Q2 2026 in Review

Nomura Holdings reduced its Royalty Pharma (RPRX) stake by 79% in Q2 2026, selling an estimated $943K and leaving 4,849 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #1625.

Nomura Holdings first reported a position in RPRX in Q3 2021 and has held it in 7 quarters since. The position peaked at $17.1M in Q3 2021. 607 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Nomura Holdings held 4,849 shares of Royalty Pharma worth $272K as of Q2 2026.
  • Nomura Holdings sold 18,116 Royalty Pharma shares in Q2 2026, an estimated $943K.
  • Royalty Pharma made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #1625 holding.
  • Nomura Holdings first reported a position in Royalty Pharma in Q3 2021 and has held it in 7 quarters since.
  • Nomura Holdings's Royalty Pharma position peaked at $17.1M in Q3 2021.
  • 607 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.